Poster: Phenotypic assessment of toxicity on hepatocyte islands
Posted: 22 December 2015 | Molecular Devices | No comments yet
In this application note you will discover how to enable phenotypic assessment of compound toxicity using a human hepatocyte co-culture model…
Drug-induced hepatotoxicity is one of the most common reasons for withdrawal of an approved drug, lending importance to the development of predictive in vitro assays for early hepatotoxicity evaluation.
Download a copy of our recent poster and find out how to enable assessment of compound toxicity on hepatocyte islands using the ImageXpress® Micro XLS System.
This poster is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- Episode 15 – Minimise variability issues in your organoids
- Episode 14 – Complex assays with Ian Shoemaker, Beckman Coulter Life Sciences & Dr Oksana Sirenko, Molecular Devices
- Episode 12 – ELISA assays with Dr Ana Miletic and Anna Dey, Kyowa Kirin & Dr Cathy Olsen, Molecular Devices
- Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
- Episode 11 – CRISPR with Dr Jakob Haaber, SNIPR Biome & Dr Richard Fox, Infinome Biosciences
Related topics
Assays, Drug Discovery, Screening
Related organisations
Molecular Devices
